Innoviva, Inc. (INVA)
21.03
-0.04
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
21.03
0.00 (0.00%)
After-Hours: 20:00
Innoviva Total Liabilities (Quarterly) : 469.46M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 469.46M |
| March 31, 2026 | 494.93M |
| December 31, 2025 | 462.32M |
| September 30, 2025 | 419.16M |
| June 30, 2025 | 618.75M |
| March 31, 2025 | 607.48M |
| December 31, 2024 | 644.32M |
| September 30, 2024 | 563.07M |
| June 30, 2024 | 559.40M |
| March 31, 2024 | 563.93M |
| December 31, 2023 | 568.55M |
| September 30, 2023 | 560.61M |
| June 30, 2023 | 563.15M |
| March 31, 2023 | 568.28M |
| December 31, 2022 | 665.71M |
| September 30, 2022 | 686.34M |
| June 30, 2022 | 572.18M |
| March 31, 2022 | 555.26M |
| December 31, 2021 | 400.46M |
| September 30, 2021 | 395.43M |
| June 30, 2021 | 395.40M |
| March 31, 2021 | 391.61M |
| December 31, 2020 | 391.73M |
| September 30, 2020 | 387.38M |
| June 30, 2020 | 386.81M |
| Date | Value |
|---|---|
| March 31, 2020 | 382.14M |
| December 31, 2019 | 382.71M |
| September 30, 2019 | 392.19M |
| June 30, 2019 | 395.60M |
| March 31, 2019 | 390.17M |
| December 31, 2018 | 389.14M |
| September 30, 2018 | 385.97M |
| June 30, 2018 | 494.06M |
| March 31, 2018 | 489.49M |
| December 31, 2017 | 610.04M |
| September 30, 2017 | 613.93M |
| June 30, 2017 | 668.75M |
| March 31, 2017 | 726.06M |
| December 31, 2016 | 731.99M |
| September 30, 2016 | 738.41M |
| June 30, 2016 | 741.21M |
| March 31, 2016 | 749.80M |
| December 31, 2015 | 766.72M |
| September 30, 2015 | 760.63M |
| June 30, 2015 | 756.08M |
| March 31, 2015 | 748.84M |
| December 31, 2014 | 745.00M |
| September 30, 2014 | 746.85M |
| June 30, 2014 | 793.14M |
| March 31, 2014 | 341.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 85.06M |
| Collegium Pharmaceutical, Inc. | 1.824B |
| CorMedix, Inc. | 443.22M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.703B |
| Shareholders Equity (Quarterly) | 1.233B |
| Debt to Equity Ratio | 0.2187 |
| Current Ratio | 16.01 |
| Net Debt Paydown Yield | 2.20% |